NCT00555269

Brief Summary

To compare possible toxicities of membrane blue and infracyanine green in vivo by macular function and peripheral visual field.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Oct 2004

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2004

Completed
1.2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2005

Completed
1.9 years until next milestone

First Submitted

Initial submission to the registry

November 7, 2007

Completed
1 day until next milestone

First Posted

Study publicly available on registry

November 8, 2007

Completed
Last Updated

April 22, 2009

Status Verified

April 1, 2009

First QC Date

November 7, 2007

Last Update Submit

April 20, 2009

Conditions

Keywords

Macular puckerMacular holeMembrane BlueInfracyanine GreenPeripheral Visual Field

Outcome Measures

Primary Outcomes (1)

  • Visual acuity, macular thickness and peripheral visual field

Study Arms (2)

MB

IFCG

Eligibility Criteria

Age40 Years - 90 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Study Population

Patients with a macular pucker or a macular hole, without any other retinal disease

You may qualify if:

  • Macular pucker or macular hole

You may not qualify if:

  • Any other retinal disease

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • Schmid-Kubista KE, Lamar PD, Schenk A, Stolba U, Binder S. Comparison of macular function and visual fields after membrane blue or infracyanine green staining in vitreoretinal surgery. Graefes Arch Clin Exp Ophthalmol. 2010 Mar;248(3):381-8. doi: 10.1007/s00417-009-1213-4. Epub 2009 Oct 13.

MeSH Terms

Conditions

Epiretinal MembraneRetinal Perforations

Condition Hierarchy (Ancestors)

Retinal DiseasesEye Diseases

Study Officials

  • Katharina E Schmid-Kubista, MD

    Ludwig Boltzmann Institute for Retinology and Biomicroscopic Lasersurgery

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER

Study Record Dates

First Submitted

November 7, 2007

First Posted

November 8, 2007

Study Start

October 1, 2004

Study Completion

December 1, 2005

Last Updated

April 22, 2009

Record last verified: 2009-04